Drug
Olanzapine 5 MG
Olanzapine 5 MG is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
50%(1 trials)
Phase Distribution
Ph phase_3
4
100%
Phase Distribution
0
Early Stage
0
Mid Stage
4
Late Stage
Phase Distribution4 total trials
Phase 3Large-scale testing
4(100.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(2)
Other(1)
Detailed Status
Completed2
unknown1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 34 (100.0%)
Trials by Status
unknown125%
completed250%
recruiting125%
Recent Activity
1 active trials
Showing 4 of 4
completedphase_3
Olanzapine Anorexia Cachexia
NCT05243251
recruitingphase_3
Olanzapine for Cancer Related Anorexia-cachexia Syndrome
NCT06517199
completedphase_3
Olanzapine for Nausea/Vomiting Prophylaxis in Recipients of Hematopoietic Stem Cell Transplants
NCT04535141
unknownphase_3
Olanzapine Versus Aprepitant Based Antiemetic Regimen for High Emetic Chemotherapy
NCT03876938
Clinical Trials (4)
Showing 4 of 4 trials
NCT05243251Phase 3
Olanzapine Anorexia Cachexia
NCT06517199Phase 3
Olanzapine for Cancer Related Anorexia-cachexia Syndrome
NCT04535141Phase 3
Olanzapine for Nausea/Vomiting Prophylaxis in Recipients of Hematopoietic Stem Cell Transplants
NCT03876938Phase 3
Olanzapine Versus Aprepitant Based Antiemetic Regimen for High Emetic Chemotherapy
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4